Posted inBiotechnology
Ketogenic Diet Worsens Colitis via Gut-Immune Axis
In a groundbreaking study published in Nature Communications, researchers have unveiled an unexpected and troubling effect of the ketogenic diet…
Posted inBiotechnology
Printable Meta-Assemblies Drive Synergetic Colouration
In a groundbreaking advance that reimagines the fabrication of optical materials, researchers have unveiled a novel meta-assembly technique capable of…
Posted inBiotechnology
GP Nurses Poised to Revolutionize Access to Sleep Care
In a groundbreaking comprehensive review published in BMC Primary Care, researchers from Flinders University have unveiled critical insights into the…
Posted inBiotechnology
Rectal Cancer Emerging Sooner and Progressing More Aggressively, Study Finds
In recent years, colorectal cancer has undergone a troubling epidemiological shift, particularly affecting younger adults who were historically considered low…
Posted inBiotechnology
Gut Bacterial Toxins at Elevated Levels Induce Lupus Nephritis
A groundbreaking study from NYU Langone Health elucidates a complex interplay between the gut microbiome and the debilitating autoimmune disease…
Posted inBiotechnology
CDKN1B Loss Fuels ER Therapy Resistance in Breast Cancer
In the evolving landscape of breast cancer treatment, hormone receptor-positive (HR+), HER2-negative breast cancer has long presented both opportunities and…
Posted inBiotechnology
Late-Night Snacking: What It Really Does to Your Gut Health
In a groundbreaking development poised to reshape our understanding of digestive health, new research reveals that the timing of food…
Posted inBiotechnology
Breakthrough Discovery: Young Microbiome Holds Key to a Healthy Liver
In a groundbreaking study poised to reshape our understanding of aging and cancer biology, researchers have unveiled compelling evidence that…
Posted inBiotechnology
Canadian Insights Into Modern Green Care Farms
In a groundbreaking study poised to reshape the future of eldercare, researchers Harris, Yous, Ling, and colleagues delve into the…
Posted inBiotechnology
Sanofi CFO defends Hudson’s Dupixent legacy, but accepts ‘number of setbacks’ in R&D
As Sanofi counts down the days before its new leader arrives, the French pharma’s chief financial officer acknowledged there had…